In the US, Sodium Phenylbutyrate (sodium phenylbutyrate systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Urea Cycle Disorders.
US matches:
- Sodium Phenylbutyrate
- Sodium Phenylbutyrate Powder
Scheme
USAN
ATC (Anatomical Therapeutic Chemical Classification)
A16AX03
CAS registry number (Chemical Abstracts Service)
0001716-12-7
Chemical Formula
C10-H11-Na-O2
Molecular Weight
186
Therapeutic Category
Drug for metabolic disease treatment
Chemical Name
Benzenebutanoic acid, sodium salt
Foreign Names
- Natrii phenylbutyras (Latin)
- Natriumphenylbutyrat (German)
- Phénylbutyrate sodique (French)
Generic Names
- Sodium Phenylbutyrate (OS: USAN, BAN)
- Natrii phenylbutyras (PH: Ph. Eur. 6)
- Sodium Phenylbutyrate (PH: Ph. Eur. 6, BP 2010)
Brand Names
- Ammonaps
Orphan, Austria; Orphan, France; Orphan, United Kingdom; Orphan, Luxembourg; Orphan, Slovakia; Swedish Orphan, Czech Republic; Swedish Orphan, Denmark; Swedish Orphan, Spain; Swedish Orphan, Finland; Swedish Orphan, Italy; Swedish Orphan, Portugal; Swedish Orphan, Sweden; Swedish Orphan, Slovenia - Buphenyl
Giraffes, Taiwan; Medicis, United States; Ucyclyd, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.